[144] Amylyx Pharmaceuticals, Inc. SEC Filing
Rhea-AI Filing Summary
AMLX insider Joshua Barry Cohen has filed a notice of proposed sale of company stock under Rule 144. The filing covers the planned sale of 1,974 common shares through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $26,688.48 based on the figures provided. The shares relate to an exercise of stock options on 01/16/2026, paid for in cash and acquired from the issuer on the same date.
The notice states that AMLX had 109,819,569 shares of common stock outstanding. Over the prior three months, sales for Cohen’s account included 136,193 common shares on 01/15/2026 for gross proceeds of $1,850,794.52 and 7,715 common shares on 01/06/2026 for gross proceeds of $85,596.38. By signing, the seller represents that he is not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.